LHC Group, Inc. operates in the Home health care services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares LHC Group with three other
companies in this sector in UNITED STATES :
Chemed Corporation
(2019
sales of $1.94 billion
of which 66%
was Vitas),
Evolent Health Inc
($846.38 million
of which 81%
was Services), and
Amedisys, Inc.
($1.96 billion
of which 64%
was Home Health Care).
Sales Analysis.
LHC Group reported sales of $2.08 billion
for the
year ending
December of 2019.
This
represents
an
increase of 14.9%
versus 2018, when the company's sales were $1.81 billion.
Sales at LHC Group have increased during each of the previous five years
(and since 2014, sales have increased a total of 184%).
Sales of Home and Community-Based Services saw an increase
of
20.8% in 2019, from
$172.50 million to $208.46 million.
Not all segments of LHC Group experienced an increase in sales in 2019:
sales of Healthcare Innovations fell 10.4% to $29.66 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
LHC Group also experienced decreases in sales in
Facility Based Services (down 1.7% to $111.81 million)
.